Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000899243-18-004667

Franchise Lead, Neurology sold 18,750 shares at $50.00 ($937,500)

  • Franchise Lead, Neurology acquired 18,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Panzara Michael A. · Franchise Lead, Neurology

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-02-15 Exercise or conversion : show line 1 in the form +18,750 $21.69 $406,688 58,486 D
2018-02-15 Sale : show line 2 in the form −18,750 $50.00 $937,500 39,736 D
Open-market sales · 18,750 sh · avg $50.00 · $937,500

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-02-15 Exercise or conversion : show line 3 in the form Share Option (right to buy) −18,750 $21.69 2026-07-11 18,750 131,250 D
Loading xslF345X03/doc4.xml…